APTYRESH-FM

APTYRESH-FM is a pharmaceutical tablet formulation containing Flupentixol 0.5 mg and Melitracen 10 mg in a single oral dosage form. The product is listed under the Psychiatric Products segment of the Suprimeda pharmaceutical portfolio and combines Flupentixol, a low-dose antipsychotic with mood-elevating properties at this strength, with Melitracen, a tricyclic antidepressant.

The formulation provides a clearly defined combination of two active pharmaceutical ingredients with specified strengths. Flupentixol 0.5 mg and Melitracen 10 mg are presented together as an oral tablet formulation, making the product suitable for professional pharmaceutical identification and institutional procurement.

From a pharmaceutical cataloguing perspective, APTYRESH-FM can be identified using relevant product terms such as Flupentixol tablets, Melitracen tablets, Flupentixol 0.5 mg, Melitracen 10 mg, Flupentixol and Melitracen tablets and psychiatric tablet formulations.